Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Autologous Transplant To End NMO Spectrum Disorder
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE4
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Multicenter Registry of Pediatric Lupus Nephritis in China
- Status
- UNKNOWN
- Phase
- N/A
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
CURATE.AI Optimized Modulation for Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2